WMSA
FLACU

Weiss Multi-Strategy Advisers’s Frazier Lifesciences Acquisition Corporation Unit FLACU Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio FLACU Stock Details FLACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,185
Closed -$164K – 808
2022
Q3 		$164K Hold
16,185
– – ﹤0.01% 618
2022
Q2 		$160K Hold
16,185
– – ﹤0.01% 624
2022
Q1 		$162K Hold
16,185
– – ﹤0.01% 635
2021
Q4 		$161K Hold
16,185
– – ﹤0.01% 621
2021
Q3 		$162K Hold
16,185
– – ﹤0.01% 638
2021
Q2 		$163K Hold
16,185
– – ﹤0.01% 638
2021
Q1 		$164K Sell
16,185
-19,224
-54% -$205K ﹤0.01% 664
2020
Q4 		$368K Buy
+35,409
New +$370K 0.01% 606

Weiss Multi-Strategy Advisers's FLACU Position: Q4 2022 in Review

Weiss Multi-Strategy Advisers sold out of Frazier Lifesciences Acquisition Corporation Unit (FLACU) in Q4 2022, closing a stake of 16,185 shares — an estimated $164K sold.

Weiss Multi-Strategy Advisers first reported a position in FLACU in Q4 2020 and held it in 8 quarters. The position peaked at $368K in Q4 2020. 0 funds tracked by Wall St. Rank hold FLACU as of Q4 2022.

  • Weiss Multi-Strategy Advisers reported no remaining Frazier Lifesciences Acquisition Corporation Unit position as of Q4 2022 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 16,185 Frazier Lifesciences Acquisition Corporation Unit shares in Q4 2022, an estimated $164K.
  • Weiss Multi-Strategy Advisers first reported a position in Frazier Lifesciences Acquisition Corporation Unit in Q4 2020 and held it in 8 quarters.
  • Weiss Multi-Strategy Advisers's Frazier Lifesciences Acquisition Corporation Unit position peaked at $368K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Unit as of Q4 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.